United States, Institutional

Changechevron_right
menu
search
Skip to main content

Health care

Showing 10 of 23 Insights Posts
1349253411
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

Private biotech: Immunology and inflammation’s third wave

Our experts discuss how I&I is building on industry progress to offer new treatment solutions and interesting opportunities for private biotech investors. 

Continue reading
event December 2024
5 min
Article
2025-12-01
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
97970762
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

Strong fundamentals, attractive valuations: Why the time may be right for active biotech investing

From solid fundamentals to supportive macro conditions, learn why our biotech experts believe the industry may be ready to run.

Continue reading
event October 2024
8 min
Article
2025-10-31
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
2032712798
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

Biotech IPOs in 2025: Quantity, quality, and best practices

We explore today's biotech IPO market, highlighting recent market trends, key characteristics for successful biotech IPOs, and best practices to sustain momentum as a public biotechnology company.

Continue reading
event August 2024
4 min
Article
2025-08-31
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
1413597282
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

Built to last? Identifying durable health care start-ups

Two members of our late-stage growth team share insights and results from their recent analysis of enterprise-value trajectories for private, non-biotech health care companies.

Continue reading
event May 2024
14 min
Article
2025-05-23
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
543195947
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

Innovation and M&A driving biotech recovery

We are optimistic that the biotech market will continue to recover, supported by innovation, an improving macroeconomic environment, continued M&A activity, and improved fundamentals for the sector.

Continue reading
event May 2024
10 min
Article
2025-04-30
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
1414387544
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

Investing at the biopharma frontier

Rebecca Sykes details groundbreaking innovations happening today in the biopharmaceutical industry. She explains key advancements and the investment landscape for therapies targeting diabetes, cancer, and Alzheimer's disease, three of the deadliest and most expensive diseases facing the world today. 

Continue reading
event November 2023
Video
2024-11-30
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
1387055829
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

Novel therapies changing the course of health care

Several new drug classes represent a growing investment opportunity set that could reshape the health care sector.

Continue reading
event October 2023
Article
2024-10-31
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
1073823296
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

Thematic investing focus: a new era for medical innovation

Advances in science, tools and technologies are transforming the face of healthcare, revolutionising the diagnosis and treatment of complex diseases. How can thematic investors identify promising opportunities?

Continue reading
event October 2023
Article
2024-09-30
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
1441707651
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

Private investing portfolio company interview with RayzeBio CEO Ken Song

Dr. Ken Song, President and CEO of RayzeBio, discusses the company’s innovative approach to radiopharmaceuticals and highlights how Wellington’s public and private investment expertise is distinctive in the health care space.

Continue reading
event October 2023
Video
2024-09-30
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
1410189307
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

Biotech for the next decade: Private market innovations

We explore our latest research in private biotech innovation across immunomodulatory therapies, precision oncology, antibody drug conjugates, radiopharmaceuticals, genetic medicines, and a range of other novel treatment modalities.

Continue reading
event July 2023
Article
2024-07-14
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.